» Articles » PMID: 39334088

Risk Factors and Distribution Pattern of Lateral Lymph Node Recurrence After Central Neck Dissection for CN1a Papillary Thyroid Carcinoma

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2024 Sep 28
PMID 39334088
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The indication and extent of selective lateral neck dissection (LND) for cN1a papillary thyroid carcinoma (PTC) remain uncertain. The present study aimed to identify potential predictors and distribution pattern of lateral lymph node recurrence (LLNR) after central neck dissection in cN1a PTC patients.

Methods: The cN1a PTC patients who underwent initial central neck dissection at our centre were retrospectively reviewed, and the median follow-up period was 6.8 years. Reoperation with LND was performed when LLNR was confirmed. Risk factors for LLNR were identified, and the metastatic status of each lateral level was recorded.

Results: Of the 310 patients enrolled in the present study, fifty-eight patients (18.7%) presented with LLNR. Six independent factors, including tumour diameter, pathological T4 stage, number of involved central lymph nodes, pTNM stage, extrathyroidal extension, and I treatment (P values < 0.05) were identified via multivariate analysis. LLNR was found at level II in 26 patients (44.8%), level III in 38 patients (65.5%), level IV in 30 patients (51.7%), and level V in 8 patients (13.8%). The number of positive lateral lymph nodes at levels II, III, IV and V was 44 (22.9%), 76 (39.6%), 63 (32.8%), and 9 (4.9%), respectively.

Conclusions: For cN1a PTC patients who underwent central neck dissection, tumour diameter ≥ 2 cm, pathological T4 stage, number of involved central lymph nodes ≥ 3, pTNM stage III-IV, extrathyroidal extension, and failure to receive I treatment were independent predictors of LLNR, which was more likely to occur at levels III and IV.

References
1.
Lee D, Song C, Ji Y, Kim J, Choi Y, Lee J . Efficacy of F-fluorodeoxyglucose PET/CT for Detecting Lymph Node Metastasis in Papillary Thyroid Carcinoma. OTO Open. 2019; 2(3):2473974X18788545. PMC: 6737877. DOI: 10.1177/2473974X18788545. View

2.
Wu L, Gu H, Qu X, Zheng J, Zhang W, Yin Y . The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: A meta-analysis. Eur J Radiol. 2011; 81(8):1798-805. DOI: 10.1016/j.ejrad.2011.04.028. View

3.
Rajeev P, Ahmed S, Ezzat T, Sadler G, Mihai R . The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer. Langenbecks Arch Surg. 2013; 398(3):377-82. DOI: 10.1007/s00423-012-1041-6. View

4.
Liu W, Yang J, Wang X, Cai W, Li F . Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level. BMC Surg. 2022; 22(1):228. PMC: 9199251. DOI: 10.1186/s12893-022-01678-w. View

5.
Shi L, Song H, Zhu H, Li D, Zhang N . Pattern, predictors, and recurrence of cervical lymph node metastases in papillary thyroid cancer. Contemp Oncol (Pozn). 2014; 17(6):504-9. PMC: 3934041. DOI: 10.5114/wo.2013.38910. View